Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
BMC Res Notes ; 10(1): 192, 2017 Jun 05.
Artigo em Inglês | MEDLINE | ID: mdl-28583187

RESUMO

BACKGROUND: Shigella is an important cause of bacterial gastroenteritis in resource-poor countries. The treatment of shigellosis mostly requires antibiotics. However, the increase of multidrug resistance along with emergence of extended-spectrum ß-lactamase and ciprofloxacin resistance among Shigella spp. has challenged the situation. This study was conducted to determine the distribution of species and antibiotic susceptibility pattern of Shigella species isolated from stool specimen among children less than 5 years of age in Nepal. RESULTS: Out of total 717 stool samples collected, 15 cases of Shigella spp. was isolated which includes 12 S. flexneri and 3 S. sonnei. Multidrug resistance was found among 13(86%) of the isolates. One of the isolates of S. flexneri was found to be ESBL-producer with MIC >256 mg/L for cefixime. CONCLUSION: The high occurrence of multidrug resistance among Shigella spp. along with a case of ESBL-production for the first time in Nepal alarms the concerns about dissemination of the resistant isolates. So, systemic monitoring of the antimicrobial susceptibility pattern of Shigella spp. is becoming crucial to guide therapy.


Assuntos
Anti-Infecciosos/uso terapêutico , Disenteria Bacilar/tratamento farmacológico , Shigella/efeitos dos fármacos , Centros de Atenção Terciária , Cefixima/uso terapêutico , Criança , Pré-Escolar , Ciprofloxacina/uso terapêutico , Resistência a Múltiplos Medicamentos , Disenteria Bacilar/microbiologia , Fezes/microbiologia , Humanos , Lactente , Testes de Sensibilidade Microbiana , Nepal , Shigella/enzimologia , Shigella/fisiologia , beta-Lactamases/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA